Cooperative Agreement UG3CA293756
Award Date
9/15/24
Completion Date
8/31/26
Dollars Obligated
$640K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Cooperative Agreement
Place of Performance
Madison, WI 53715, USA
Similar Awards
This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
This federal Cooperative Agreement award, totaling $653,951 and funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), aims to implement and evaluate sustainable mobile health (mHealth) smoking cessation interventions for people with HIV in Laos. The project, titled "Implementing Sustainable Mobile Health Technology to Optimize Smoking Cessation Program for Lao People with HIV (I-STOP)," will compare two smoking cessation implementation...
This federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $728,006 to the University of Chicago to conduct a 2x2 factorial randomized controlled trial. The study aims to optimize treatment of co-occurring smoking and unhealthy alcohol use among people with HIV in Nairobi, Kenya. The key products and services to be delivered include: Evaluating the efficacy of an intensive behavioral counseling...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $1,226,040 to the Regents of the University of Minnesota to conduct a randomized clinical trial of a culturally-tailored suite of smoking cessation resources for American Indian persons. The key objectives are to: Co-create a culturally-aligned website, "Smokefree.gov for Natives", to serve as the landing page for digital cessation resources tailored for American...
The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) will fund the development and evaluation of smoking health communications targeted to adults who smoke nondaily (ASN). The $164,484 award, effective August 11, 2025 through July 31, 2027, will support two main aims: Developing and iteratively refining smoking cessation messages for ASN that vary in affective valence (positive vs. negative) and type of consequences (social vs....
This Project Grant award of $515,632 from the National Cancer Institute's (NCI) Cancer Cause and Prevention Research program (CFDA 93.393) supports research to prepare the U.S. and state governments for the potential implementation of two cigarette product standards by the FDA - a menthol ban and a nicotine reduction standard. The key objectives are to: 1) Estimate for each U.S. state the increase in people who smoke that would quit and enroll in quit lines following the implementation of...
This Project Grant award of $899,273.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The purpose of the award is to support a research project titled "Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients." The research will be conducted by Washington University in St. Louis, with a sub-award to the Vandeventer Place Research Foundation. The project aims to explore...
This Cooperative Agreement award, funded by the National Center for Chronic Disease Prevention and Health Promotion under the Centers for Research and Demonstration for Health Promotion and Disease Prevention (CFDA 93.135) program, is supporting the implementation of a culturally appropriate digital health intervention to reduce tobacco-related cancer disparities among Hispanic/Latinx communities. The total award is $600,000 and will be completed by September 29, 2029. A sub-award of undisclosed...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $667,828 to Case Western Reserve University to adapt, implement, and evaluate the effectiveness of a tobacco cessation outreach model in community-based food pantry settings. The primary goals are to increase the reach and impact of tobacco quitline services among socioeconomically disadvantaged populations who smoke, a group that faces substantial barriers to accessing...